MetLife, Inc. $MET Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lowered its holdings in MetLife, Inc. (NYSE:MET) by 50.4% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 44,541 shares of the financial services provider’s stock after selling 45,235 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in MetLife were worth $3,669,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in MET. Blue Trust Inc. increased its position in shares of MetLife by 3.6% during the third quarter. Blue Trust Inc. now owns 3,585 shares of the financial services provider’s stock worth $295,000 after acquiring an additional 125 shares during the period. Daymark Wealth Partners LLC grew its stake in MetLife by 4.2% during the 3rd quarter. Daymark Wealth Partners LLC now owns 3,192 shares of the financial services provider’s stock worth $263,000 after purchasing an additional 130 shares in the last quarter. Ignite Planners LLC increased its holdings in MetLife by 2.2% during the 2nd quarter. Ignite Planners LLC now owns 6,366 shares of the financial services provider’s stock worth $491,000 after purchasing an additional 136 shares during the period. Legacy Capital Wealth Partners LLC raised its position in MetLife by 3.2% in the 2nd quarter. Legacy Capital Wealth Partners LLC now owns 4,355 shares of the financial services provider’s stock valued at $350,000 after purchasing an additional 137 shares in the last quarter. Finally, Abound Wealth Management boosted its stake in shares of MetLife by 29.9% in the 3rd quarter. Abound Wealth Management now owns 635 shares of the financial services provider’s stock valued at $52,000 after buying an additional 146 shares during the period. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Down 0.5%

MET opened at $79.37 on Friday. MetLife, Inc. has a one year low of $65.21 and a one year high of $88.09. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.18 and a current ratio of 0.18. The stock has a market capitalization of $52.30 billion, a P/E ratio of 14.95, a price-to-earnings-growth ratio of 0.72 and a beta of 0.76. The business’s 50-day simple moving average is $78.77 and its 200-day simple moving average is $79.02.

MetLife (NYSE:MET) last released its quarterly earnings results on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.30 by $0.07. MetLife had a return on equity of 21.00% and a net margin of 5.30%.The firm had revenue of $12.46 billion for the quarter, compared to the consensus estimate of $18.64 billion. During the same quarter last year, the business posted $1.95 EPS. The firm’s quarterly revenue was down 5.9% compared to the same quarter last year. Analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd will be given a $0.5675 dividend. The ex-dividend date is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a yield of 2.9%. MetLife’s dividend payout ratio is 42.75%.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Evercore ISI set a $97.00 target price on shares of MetLife and gave the company an “in-line” rating in a report on Tuesday. Mizuho assumed coverage on shares of MetLife in a research report on Monday, December 15th. They issued an “outperform” rating and a $101.00 price objective on the stock. Barclays set a $90.00 target price on shares of MetLife in a research note on Thursday. Keefe, Bruyette & Woods cut their price target on MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 11th. Finally, Piper Sandler downgraded MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price target for the company. in a report on Friday, September 19th. Two analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, MetLife currently has an average rating of “Moderate Buy” and an average target price of $95.08.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.